Symbols / GELS $0.80 +2.56%
GELS Chart
About
Gelteq Limited focuses on developing and commercializing white label gel-based delivery solutions for humans and animals in the United States of America and Australia. It offers edible gels for prescription drugs, nutraceuticals, pet care, and other products, as well as for sports and over-the-counter products. Gelteq Limited was incorporated in 2017 and is headquartered in Clayton, Australia.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Drug Manufacturers - Spe | Market Cap | 8.57M |
| Enterprise Value | 12.44M | Income | -6.65M | Sales | 413.13K |
| Book/sh | 1.10 | Cash/sh | 0.03 | Dividend Yield | — |
| Payout | 0.00% | Employees | 7 | IPO | — |
| P/E | — | Forward P/E | — | PEG | — |
| P/S | 20.74 | P/B | 0.73 | P/C | — |
| EV/EBITDA | -3.24 | EV/Sales | 30.11 | Quick Ratio | 0.14 |
| Current Ratio | 0.27 | Debt/Eq | 26.68 | LT Debt/Eq | — |
| EPS (ttm) | -0.50 | EPS next Y | — | EPS Growth | — |
| Revenue Growth | 59.40% | Earnings | — | ROA | -15.00% |
| ROE | -42.99% | ROIC | — | Gross Margin | 72.07% |
| Oper. Margin | -29.69% | Profit Margin | 0.00% | Shs Outstand | 10.71M |
| Shs Float | 5.46M | Short Float | 1.91% | Short Ratio | 4.23 |
| Short Interest | — | 52W High | 4.11 | 52W Low | 0.64 |
| Beta | — | Avg Volume | 1.06M | Volume | 13.18K |
| Target Price | — | Recom | None | Prev Close | $0.78 |
| Price | $0.80 | Change | 2.56% |
Valuation Models
Price estimates from analyst targets and simple models.
Ratings
- Gel-based medicinal cannabis boosts CBD uptake 22%+ in early tests - Stock Titan ue, 13 Jan 2026 08
- GELS Stock: Market Movements Reflect Strategic Challenges - StocksToTrade Wed, 14 Jan 2026 08
- Genesis Energy, L.P. (GEL) Up More Than 52% YTD, Here’s What You Need to Know - Yahoo Finance Sun, 14 Dec 2025 08
- What's Driving Gelteq Ltd.'s (GELS) Over 69% After-Hours Surge? - Benzinga ue, 13 Jan 2026 08
- European Union bans key ingredient in gel nail polish - abcnews.com ue, 02 Sep 2025 07
- Gelteq (GELS) gel platform boosts antihistamine bioavailability 38–45% in preclinical study - Stock Titan Mon, 24 Nov 2025 08
- GELS Stock Sees New Inflection Point Amid Market Volatility - timothysykes.com Wed, 14 Jan 2026 08
- Energy Gels Market Size, Share | CAGR of 7.1% - Market.us Mon, 05 Jan 2026 13
- Seqens Expands Green Offerings with 4 Next-Gen Additions to its AdvensProtect Portfolio - Cosmetics & Toiletries Mon, 05 Jan 2026 08
- This Common Gel Nail Polish Ingredient Just Got Banned in Europe for Being Potentially Toxic to Humans - People.com Wed, 03 Sep 2025 07
- Why gel nail polishes are banned in Europe starting today — but not in the US - nypost.com Mon, 01 Sep 2025 07
- Why I Recently Bought Energy Transfer Instead Of Genesis Energy (ET) (GEL) - Seeking Alpha Sat, 16 Aug 2025 07
- Glowing gels and pipettes aplenty: how do commercial stock image banks portray genetic tests? - Nature Fri, 08 Dec 2023 08
- GELS Stock Price and Chart — NASDAQ:GELS - TradingView ue, 29 Oct 2024 15
- Why Gelteq Shares Are Trading Higher By 50%; Here Are 20 Stocks Moving Premarket - Benzinga Wed, 14 Jan 2026 08
Insider Transactions
No recent insider transactions.
Financials
| Line Item | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | 0.00 | 0.00 | 0.00 | 0.00 |
| TaxRateForCalcs | 0.00 | 0.00 | 0.00 | 0.00 |
| NormalizedEBITDA | -3.78M | -1.41M | -2.15M | -1.98M |
| TotalUnusualItems | 256.22K | -338.31K | 277.51K | 1.02K |
| TotalUnusualItemsExcludingGoodwill | 256.22K | -338.31K | 277.51K | 1.02K |
| NetIncomeFromContinuingOperationNetMinorityInterest | -6.65M | -3.55M | -3.51M | -3.37M |
| ReconciledDepreciation | 1.22M | 1.21M | 1.23M | 1.22M |
| ReconciledCostOfRevenue | 0.00 | 48.92K | 94.87K | 0.00 |
| EBITDA | -3.53M | -1.75M | -1.88M | -1.98M |
| EBIT | -4.75M | -2.96M | -3.10M | -3.19M |
| NetInterestIncome | -1.95M | -600.22K | -404.07K | -175.63K |
| InterestExpense | 1.89M | 585.12K | 403.52K | 174.50K |
| NormalizedIncome | -6.90M | -3.21M | -3.78M | -3.37M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -6.65M | -3.55M | -3.51M | -3.37M |
| TotalExpenses | 5.12M | 2.61M | 3.46M | 3.34M |
| TotalOperatingIncomeAsReported | -5.50M | -2.95M | -3.10M | -3.19M |
| DilutedAverageShares | 9.44M | 9.44M | 9.44M | 9.44M |
| BasicAverageShares | 9.44M | 9.44M | 9.44M | 9.44M |
| DilutedEPS | -0.38 | -0.37 | -0.36 | -0.07 |
| BasicEPS | -0.38 | -0.37 | -0.36 | -0.07 |
| DilutedNIAvailtoComStockholders | -6.65M | -3.55M | -3.51M | -3.37M |
| NetIncomeCommonStockholders | -6.65M | -3.55M | -3.51M | -3.37M |
| NetIncome | -6.65M | -3.55M | -3.51M | -3.37M |
| NetIncomeIncludingNoncontrollingInterests | -6.65M | -3.55M | -3.51M | -3.37M |
| NetIncomeContinuousOperations | -6.65M | -3.55M | -3.51M | -3.37M |
| TaxProvision | 0.00 | 0.00 | 0.00 | 0.00 |
| PretaxIncome | -6.65M | -3.55M | -3.51M | -3.37M |
| OtherIncomeExpense | 256.22K | -338.31K | 277.51K | 1.02K |
| OtherNonOperatingIncomeExpenses | -8.76K | |||
| SpecialIncomeCharges | -200.74K | -341.88K | 222.68K | 0.00 |
| OtherSpecialCharges | 200.74K | 166.80K | -222.68K | |
| WriteOff | 0.00 | 175.08K | 0.00 | |
| GainOnSaleOfSecurity | 456.96K | 3.57K | 54.83K | 1.02K |
| NetNonOperatingInterestIncomeExpense | -1.95M | -600.22K | -404.07K | -175.63K |
| TotalOtherFinanceCost | 55.94K | 15.10K | 548.00 | 1.13K |
| InterestExpenseNonOperating | 1.89M | 585.12K | 403.52K | 174.50K |
| OperatingIncome | -4.95M | -2.61M | -3.38M | -3.19M |
| OperatingExpense | 5.12M | 2.61M | 3.41M | 3.25M |
| OtherOperatingExpenses | 1.04M | 11.66K | -21.85K | 71.87K |
| OtherTaxes | 4.57K | 17.02K | 14.58K | 0.00 |
| DepreciationAmortizationDepletionIncomeStatement | 1.22M | 1.21M | 1.23M | 1.22M |
| DepreciationAndAmortizationInIncomeStatement | 1.22M | 1.21M | 1.23M | 1.22M |
| Amortization | 1.22M | 1.20M | 1.20M | 1.20M |
| AmortizationOfIntangiblesIncomeStatement | 1.22M | 1.20M | 1.20M | 1.20M |
| DepreciationIncomeStatement | 3.85K | 11.17K | 30.00K | 20.00K |
| ResearchAndDevelopment | 628.61K | 276.06K | 665.03K | 529.02K |
| SellingGeneralAndAdministration | 2.22M | 1.09M | 1.53M | 1.43M |
| SellingAndMarketingExpense | 204.08K | 18.20K | 166.93K | 68.44K |
| GeneralAndAdministrativeExpense | 2.02M | 1.07M | 1.36M | 1.36M |
| OtherGandA | 1.54M | 214.27K | 621.39K | 1.06M |
| SalariesAndWages | 476.50K | 858.56K | 738.01K | 306.84K |
| GrossProfit | 0.00 | 30.92K | 52.66K | 0.00 |
| CostOfRevenue | 0.00 | 48.92K | 94.87K | 0.00 |
| TotalRevenue | 165.65K | 0.00 | 79.84K | 147.54K |
| OperatingRevenue | 165.65K | 0.00 | 79.84K | 147.54K |
| Line Item | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| OrdinarySharesNumber | 10.03M | 9.44M | 9.44M | 9.44M |
| ShareIssued | 10.03M | 9.44M | 9.44M | 9.44M |
| NetDebt | 3.87M | 3.82M | 2.08M | 1.30M |
| TotalDebt | 4.22M | 3.84M | 2.49M | 1.51M |
| TangibleBookValue | -4.05M | -5.33M | -2.84M | -1.79M |
| InvestedCapital | 20.02M | 18.96M | 21.14M | 22.32M |
| WorkingCapital | -4.13M | -3.56M | -373.55K | -360.89K |
| NetTangibleAssets | -4.05M | -5.33M | -2.84M | -1.79M |
| CapitalLeaseObligations | 0.00 | 11.90K | 46.60K | 0.00 |
| CommonStockEquity | 15.80M | 15.11M | 18.66M | 20.86M |
| TotalCapitalization | 15.82M | 16.87M | 21.13M | 22.32M |
| TotalEquityGrossMinorityInterest | 15.80M | 15.11M | 18.66M | 20.86M |
| StockholdersEquity | 15.80M | 15.11M | 18.66M | 20.86M |
| GainsLossesNotAffectingRetainedEarnings | 0.00 | 0.00 | 34.72K | 0.00 |
| RetainedEarnings | -18.14M | -11.50M | -7.95M | -4.48M |
| CapitalStock | 33.95M | 26.61M | 26.61M | 25.30M |
| CommonStock | 33.95M | 26.61M | 26.61M | 25.30M |
| TotalLiabilitiesNetMinorityInterest | 5.67M | 5.65M | 3.84M | 2.55M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 38.54K | 1.78M | 2.47M | 1.47M |
| EmployeeBenefits | 24.99K | 20.02K | 0.00 | |
| LongTermDebtAndCapitalLeaseObligation | 13.55K | 1.76M | 2.47M | 1.47M |
| LongTermCapitalLeaseObligation | 0.00 | 11.90K | 0.00 | |
| LongTermDebt | 13.55K | 1.76M | 2.47M | 1.46M |
| CurrentLiabilities | 5.63M | 3.87M | 1.36M | 1.08M |
| OtherCurrentLiabilities | 771.48K | |||
| CurrentDeferredLiabilities | 0.00 | 125.36K | 85.36K | 119.77K |
| CurrentDeferredRevenue | 0.00 | 125.36K | 85.36K | 119.77K |
| CurrentDebtAndCapitalLeaseObligation | 4.20M | 2.08M | 16.98K | 39.79K |
| CurrentCapitalLeaseObligation | 0.00 | 11.90K | 34.71K | 0.00 |
| CurrentDebt | 4.20M | 2.08M | 5.09K | 5.09K |
| OtherCurrentBorrowings | 4.20M | 2.08M | 5.09K | 5.09K |
| PensionandOtherPostRetirementBenefitPlansCurrent | 84.69K | 98.37K | 77.78K | 39.52K |
| PayablesAndAccruedExpenses | 572.09K | 1.56M | 1.18M | 881.89K |
| CurrentAccruedExpenses | 100.14K | 465.64K | 577.22K | 376.08K |
| Payables | 471.96K | 1.09M | 607.18K | 505.81K |
| OtherPayable | 134.04K | 133.54K | 228.66K | 240.77K |
| DuetoRelatedPartiesCurrent | 0.00 | 224.49K | ||
| TotalTaxPayable | 155.28K | 347.49K | 87.25K | 48.31K |
| AccountsPayable | 182.63K | 387.03K | 291.27K | 216.72K |
| TotalAssets | 21.48M | 20.76M | 22.49M | 23.41M |
| TotalNonCurrentAssets | 19.97M | 20.45M | 21.50M | 22.69M |
| NonCurrentPrepaidAssets | 94.61K | 0.00 | ||
| GoodwillAndOtherIntangibleAssets | 19.86M | 20.44M | 21.49M | 22.65M |
| OtherIntangibleAssets | 19.86M | 20.44M | 21.49M | 22.65M |
| NetPPE | 15.91K | 16.64K | 10.00K | 40.00K |
| AccumulatedDepreciation | 0.00 | -50.01K | -20.00K | 0.00 |
| GrossPPE | 15.91K | 16.64K | 60.01K | 60.01K |
| Leases | 60.01K | 0.00 | ||
| OtherProperties | 15.91K | 16.64K | 60.01K | 60.01K |
| BuildingsAndImprovements | 0.00 | 60.01K | 60.01K | 0.00 |
| Properties | 0.00 | 0.00 | 0.00 | 0.00 |
| CurrentAssets | 1.51M | 303.23K | 990.97K | 720.07K |
| OtherCurrentAssets | 437.86K | 16.07K | 3.79K | 98.75K |
| PrepaidAssets | 264.44K | 79.63K | 147.47K | 112.97K |
| Inventory | 0.00 | 95.20K | 95.20K | 0.00 |
| RawMaterials | 0.00 | 95.20K | 95.20K | 0.00 |
| Receivables | 459.72K | 183.00K | 345.29K | 250.67K |
| DuefromRelatedPartiesCurrent | 0.00 | |||
| TaxesReceivable | 413.79K | 174.75K | 263.06K | 242.69K |
| AccountsReceivable | 45.93K | 8.25K | 82.23K | 7.98K |
| CashCashEquivalentsAndShortTermInvestments | 344.65K | 24.52K | 399.22K | 162.49K |
| CashAndCashEquivalents | 344.65K | 24.52K | 399.22K | 162.49K |
| CashFinancial | 344.65K | 24.52K | 399.22K | 162.49K |
| Line Item | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| FreeCashFlow | -6.16M | -1.22M | -1.85M | -1.51M |
| RepaymentOfDebt | -844.49K | -11.89K | -34.71K | -6.00K |
| IssuanceOfDebt | 1.33M | 855.83K | 755.93K | 1.49M |
| IssuanceOfCapitalStock | 7.91M | 0.00 | 1.43M | 0.00 |
| CapitalExpenditure | -642.23K | -148.17K | -75.93K | |
| EndCashPosition | 344.65K | 24.52K | 399.22K | 162.49K |
| BeginningCashPosition | 24.52K | 399.22K | 162.49K | 181.66K |
| EffectOfExchangeRateChanges | 125.07K | 0.00 | 52.56K | 1.02K |
| ChangesInCash | 195.06K | -374.70K | 184.18K | -20.20K |
| FinancingCashFlow | 6.45M | 843.94K | 2.03M | 1.49M |
| CashFlowFromContinuingFinancingActivities | 6.45M | 843.94K | 2.03M | 1.49M |
| NetOtherFinancingCharges | -1.94M | -121.84K | ||
| NetCommonStockIssuance | 7.91M | 0.00 | 1.43M | 0.00 |
| CommonStockIssuance | 7.91M | 0.00 | 1.43M | 0.00 |
| NetIssuancePaymentsOfDebt | 482.77K | 843.94K | 721.23K | 1.49M |
| NetLongTermDebtIssuance | 482.77K | 843.94K | 721.23K | 1.49M |
| LongTermDebtPayments | -844.49K | -11.89K | -34.71K | -6.00K |
| LongTermDebtIssuance | 1.33M | 855.83K | 755.93K | 1.49M |
| InvestingCashFlow | -736.84K | -148.17K | -75.93K | 0.00 |
| CashFlowFromContinuingInvestingActivities | -736.84K | -148.17K | -75.93K | 0.00 |
| NetOtherInvestingChanges | -94.61K | |||
| NetBusinessPurchaseAndSale | 0.00 | 138.89K | ||
| SaleOfBusiness | 0.00 | 138.89K | ||
| NetIntangiblesPurchaseAndSale | -639.12K | -145.02K | -41.43K | 0.00 |
| PurchaseOfIntangibles | -639.12K | -145.02K | -41.43K | 0.00 |
| NetPPEPurchaseAndSale | -3.12K | -3.15K | -34.50K | 0.00 |
| PurchaseOfPPE | -3.12K | -3.15K | -34.50K | 0.00 |
| CashFlowsfromusedinOperatingActivitiesDirect | -5.52M | -1.07M | -1.77M | -1.51M |
| TaxesRefundPaidDirect | 0.00 | 263.06K | 224.54K | 159.87K |
| InterestPaidDirect | -32.87K | -727.00 | -1.84K | -368.00 |
| ClassesofCashPayments | -5.49M | -1.37M | -2.04M | -1.93M |
| PaymentstoSuppliersforGoodsandServices | -5.49M | -1.37M | -2.04M | -1.93M |
| ClassesofCashReceiptsfromOperatingActivities | 303.06K | 269.97K | 419.19K | 244.12K |
| ReceiptsfromGovernmentGrants | 0.00 | 48.46K | ||
| ReceiptsfromCustomers | 0.00 | 40.00K | 45.44K | 259.32K |
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Public Trades for GELS
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|